Angiotensin II AT1 receptor antagonism prevents detrimental renal actions of acute diuretic therapy in human heart failure

被引:40
作者
Chen, HH [1 ]
Redfield, MM [1 ]
Nordstrom, LJ [1 ]
Cataliotti, A [1 ]
Burnett, JC [1 ]
机构
[1] Mayo Clin & Mayo Fdn, Div Cardiovasc Dis, Cardiorenal Res Lab, Rochester, MN 55905 USA
关键词
kidney; congestive heart failure; aldosterone; glomerular filtration rate;
D O I
10.1152/ajprenal.00337.2002
中图分类号
Q4 [生理学];
学科分类号
071003 [生理学];
摘要
Although effective in relieving symptoms of edema in congestive heart failure ( CHF), diuretic- induced natriuresis may be associated with reductions in glomerular filtration rate ( GFR) and effective renal plasma flow ( ERPF), which subsequently may reduce the duration of natriuresis. Moreover, recent studies have reported that the preservation of GFR is an important predictor of survival in human CHF. We hypothesized that the acute detrimental renal hemodynamic and tubular responses to furosemide in symptomatic human CHF will be attenuated by AT(1) receptor blockade with losartan. We defined the renal hemodynamic and tubular actions and aldosterone responses to furosemide ( 40 mg, orally) in the presence of acute AT(1) receptor antagonism ( losartan, MSD, 50 mg orally) vs. placebo in 10 subjects with CHF ( New York Heart Association II- III) in a double- blind, placebo- controlled crossover study. Furosemide with placebo increased sodium excretion and reduced ERPF and GFR ( P < 0.05 vs. baseline). After 4 h, sodium excretion compared with baseline was decreased ( P < 0.05). In contrast, furosemide with losartan resulted in a greater increase in sodium excretion but without reductions in ERPF and GFR ( P < 0.05 vs. placebo). After 4 h, sodium excretion was greater compared with the placebo group. Importantly, plasma aldosterone tended to increase in the placebo group, whereas it was decreased ( P < 0.05 vs. baseline) only in the losartan group. These studies underscore the pathophysiological role of the AT(1) receptor in mediating detrimental renal and adrenal properties of diuretics in human CHF. AT(1) receptor antagonism preserves GFR and renal blood flow and enhances sodium excretion during acute diuretic therapy in addition to inhibiting aldosterone secretion. These findings support the use of AT(1) receptor blockade for human CHF requiring acute diuretics to improve renal hemodynamic and tubular function and to suppress aldosterone.
引用
收藏
页码:F1115 / F1119
页数:5
相关论文
共 14 条
[1]
RENAL-SPECIFIC ACTIONS OF ANGIOTENSIN-II RECEPTOR ANTAGONISM IN THE ANESTHETIZED DOG [J].
CHAN, DP ;
SANDOK, EK ;
AARHUS, LL ;
HEUBLEIN, DM ;
BURNETT, JC .
AMERICAN JOURNAL OF HYPERTENSION, 1992, 5 (06) :354-360
[2]
Endogenous natriuretic peptides participate in renal and humoral actions of acute vasopeptidase inhibition in experimental mild heart failure [J].
Chen, HH ;
Lainchbury, JG ;
Matsuda, Y ;
Harty, GJ ;
Burnett, JC .
HYPERTENSION, 2001, 38 (02) :187-191
[3]
The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction [J].
Dries, DL ;
Exner, DV ;
Domanski, MJ ;
Greenberg, B ;
Stevenson, LW .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (03) :681-689
[4]
Diuretic complications [J].
Greenberg, A .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2000, 319 (01) :10-24
[5]
Renal function, neurohormonal activation, and survival in patients with chronic heart failure [J].
Hillege, HL ;
Girbes, ARJ ;
de Kam, PJ ;
Boomsma, F ;
de Zeeuw, D ;
Charlesworth, A ;
Hampton, JR ;
van Veldhuisen, DJ .
CIRCULATION, 2000, 102 (02) :203-+
[6]
CONTROL OF GLOMERULAR-FILTRATION RATE - ROLE OF INTRARENALLY FORMED ANGIOTENSIN-II [J].
KASTNER, PR ;
HALL, JE ;
GUYTON, AC .
AMERICAN JOURNAL OF PHYSIOLOGY, 1984, 246 (06) :F897-F906
[7]
Angiotensin II in the evolution of experimental heart failure [J].
Luchner, A ;
Stevens, TL ;
Borgeson, DD ;
Redfield, MM ;
Bailey, JE ;
Sandberg, SM ;
Heublein, DM ;
Burnett, JC .
HYPERTENSION, 1996, 28 (03) :472-477
[8]
MENDELSOHN FAO, 1987, KIDNEY INT, V31, pS40
[9]
NAVIS G, 2000, BRENNERS RECTORS KID, P2341
[10]
Renal hemodynamic effects in patients with moderate to severe heart failure during chronic treatment with trandolapril [J].
van der Ent, M ;
Remme, WJ ;
de Leeuw, PW ;
Bartels, GL .
CARDIOVASCULAR DRUGS AND THERAPY, 1998, 12 (04) :395-403